TRU vs CME
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
TRU · TransUnion$81.18 ▼ 2.09%
CME · CME Group$305.89 ▼ 0.44%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- TRU +1.6%
- CME +14.6%
Head to head
| Metric | TRU | CME |
|---|---|---|
| Price | $81.18 | $305.89 |
| Change today | ▼ 2.09% | ▼ 0.44% |
| Market cap | $15.48B | $109.49B |
| Return, 3 months | +2.7% | +16.6% |
| Return, year to date | -4.9% | +15.8% |
| Return, 1 year | +1.4% | +14.9% |
| P/E (TTM) | 19.8 | 25.1 |
| P/B | 3.2 | 4.1 |
| P/E percentile vs own 5y | 42nd | 47th |
| Dividend yield | 0.60% | 3.69% |
| Revenue growth (YoY, latest qtr) | +12.2% | +13.0% |
| Net profit growth (YoY) | +60.2% | +14.2% |
| Gross margin | 58.8% | 86.6% |
| Operating margin | 19.4% | 65.7% |
| Net margin | 15.8% | 63.1% |
| Return on equity | 17.1% | 16.1% |
| Analyst target vs. price | +12.2% | +2.5% |
| Analyst buy share | 71% | 55% |
| RSI (14) | 61 | 64 |
| 30-day volatility | 54.0% | 24.2% |
| Max drawdown, 1 year | -30.2% | -31.1% |
| Trend read | Strong uptrend | Strong uptrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- CME is the largest of the group by market value.
- CME has returned the most over the past year.
- TRU carries the lowest trailing P/E.
- CME pays the highest dividend yield.
- CME is growing revenue fastest.
- CME keeps the most profit per dollar of sales.
- CME has been the calmest stock over the last 30 days.